PolyActiva
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
45-47 Normanby Rd Unit 21, Notting Hill,...Phone Number
+61 396570777Website
www.polyactiva.comRevenue
$5.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About PolyActiva
PolyActiva specializes in innovative biodegradable implants that provide sustained drug delivery to enhance patient outcomes for those suffering from ophthalmic diseases like glaucoma. Their versatile Prezia Sustained Drug Delivery Technology platform is grounded in extensive scientific research, allowing for precise and controlled delivery of medication. Recently, they showcased promising Phase 2 clinical data demonstrating significant intraocular pressure reductions in glaucoma patients. PolyActiva aims to improve the quality of life for patients with effective long-term treatment options.Explore more
PolyActiva Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is PolyActiva your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if PolyActiva had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at PolyActiva
Product Launch: Get notified when PolyActiva launches new products
PolyActiva, which may be a good buyer, showed buying intent in Masked Content Topic
Check if PolyActiva has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once PolyActiva has new funding data
Earning: See what the market has to say on PolyActiva recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if PolyActiva is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to PolyActiva
Compare insights from companies similar to PolyActiva, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
PolyActiva is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
PolyActiva is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about PolyActiva.
PolyActiva financials insights
Gather financial insights about PolyActiva, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2011
Series A
$1.6M
2013
Series B
$9.5M
2025
Series C
$25.8M
PolyActiva Tech Stack
A closer look at the technologies used by PolyActiva
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Facilities Relocation / Expansion
Facilities Relocation/Expansion, Real Estate, Office Operations, Clinical Operations, Operations
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire, Board of Directors
PolyActiva News & Media
PolyActiva Expands Executive Team to Drive Transformational Growth and Advance Late-Stage Clinical Development in the U.S.
FORT WORTH, Texas & MELBOURNE, Australia--(BUSINESS WIRE)--PolyActiva, a clinical-stage biopharmaceutical company pioneering a novel drug delivery technology to improve outcomes for patients with ocular conditions, today announced the appointments of Wes Brazell as Chief Financial Officer (CFO) and Michael Brubaker, PhD, as Chief Scientific Officer (CSO). “Wes and Mike bring exceptional expertise in their respective fields and a shared commitment to innovation and value creation in ophthalmologBiopharmaceutical company headquartered in Fort Worth and Australia names new CEO
PolyActiva, a clinical-stage biopharmaceutical company pioneering a novel drug delivery technology to improve outcomes for patients with ocularPolyActiva secures $40 million AUD in Series C funding
Funding will support the continued clinical advancement of its lead ocular implant candidate, PA5108, for the reduction of IOP in patients with ocular hypertension and glaucoma.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding PolyActiva
Sign Up For FreeTo access detailed company insights
PolyActiva specializes in innovative biodegradable implants that provide sustained drug delivery to enhance patient outcomes for those suffering from ophthalmic diseases like glaucoma. Their versatile Prezia Sustained Drug Delivery Technology platform is grounded in extensive scientific research, allowing for precise and controlled delivery of medi... Read More
